Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Cancer|August 4, 2024
The relationship of mental health symptoms to chemotherapy toxicity risk in older adults with cancer: Results from the geriatric assessment-driven intervention studyReena V Jayani, Anahid Hamparsumian, Canlan Sun, et al.
Pancreas|July 1, 2022
Feasibility and Satisfaction of Using NET VITALS Self-assessment Tool Among Patients With Neuroendocrine TumorsDaneng Li, Giovanna J Imbesi, Lisa Yen, et al.
Journal of Geriatric Oncology|April 19, 2022
Anal cancer in older adults: A Young International Society of Geriatric Oncology review paperBertha Alejandra Martinez-Cannon, Ana Cristina Torres Perez, Jacobo Hincapie-Echeverri, et al.
American Journal of Surgery|September 3, 2021
Presentation and survival of gastro-entero-pancreatic neuroendocrine tumors in young adults versus older patientsAndrew H Nguyen, Michael P O'Leary, James P De Andrade, et al.
Liver Cancer|December 17, 2024
Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150Richard S Finn, Peter R Galle, Michel Ducreux, et al.
Journal of the American Geriatrics Society|August 19, 2007
Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practiceArti Hurria, Stuart M Lichtman, Jonathan Gardes, et al.
Investigational New Drugs|April 19, 2023
A dose escalation/expansion study evaluating dose, safety, and efficacy of the novel tyrosine kinase inhibitor surufatinib, which inhibits VEGFR 1, 2, & 3, FGFR 1, and CSF1R, in US patients with neuroendocrine tumorsArvind Dasari, Erika P Hamilton, Gerald S Falchook, et al.
Eclinicalmedicine|January 11, 2024
Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021)Daneng Li, Yohann Loriot, Adam M Burgoyne, et al.
Cancers|August 27, 2021
Patterns of Whole Exome Sequencing in Resected CholangiocarcinomaLucas W Thornblade, Paul Wong, Daneng Li, et al.
Oncotarget|November 8, 2017
A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapyMay Cho, Jun Gong, Paul Frankel, et al.
Pageof 11